Vivavision Biotech, Inc
Clinical trials sponsored by Vivavision Biotech, Inc, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a new eye drop tame uveitis inflammation without steroids? Results expected Dec 2026 (estimated)
- Can a new eye drop soothe dry, damaged eyes? Results expected Apr 2027 (estimated)
-
Can a new eye drop soothe dry, damaged eyes?
Disease control Recruiting nowThis trial tests whether an experimental eye drop called VVN001 can improve signs and symptoms of dry eye disease in Chinese adults aged 30 to 80. Participants receive either the active drop or a placebo (vehicle) for about 12 weeks. The study measures changes in corneal staining…
Phase 3 • Sponsor: VivaVision Biotech, Inc • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New nasal spray aims to ease chronic sinus troubles
Symptom relief Recruiting nowThis early-stage study tests a new nasal spray called VVN432 in 60 people. First, healthy volunteers will check for safety. Then, patients with chronic sinusitis will test if it helps symptoms. The goal is to see if the spray is safe and how the body processes it.
Phase 1 • Sponsor: VivaVision Biotech, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC